These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 15216400

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
    Jauregui LE, Babazadeh S, Seltzer E, Goldberg L, Krievins D, Frederick M, Krause D, Satilovs I, Endzinas Z, Breaux J, O'Riordan W.
    Clin Infect Dis; 2005 Nov 15; 41(10):1407-15. PubMed ID: 16231250
    [Abstract] [Full Text] [Related]

  • 3. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W.
    Int J Antimicrob Agents; 2008 Sep 15; 32(3):241-9. PubMed ID: 18635341
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM, Biswas P, Reisman A, Bhattacharyya H, Baruch AM.
    Clin Ther; 2012 Aug 15; 34(8):1667-73.e1. PubMed ID: 22770644
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of linezolid in children.
    Saiman L, Goldfarb J, Kaplan SA, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep 15; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
    Wilcox M, Nathwani D, Dryden M.
    J Antimicrob Chemother; 2004 Feb 15; 53(2):335-44. PubMed ID: 14729745
    [Abstract] [Full Text] [Related]

  • 8. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
    Li JZ, Willke RJ, Rittenhouse BE, Rybak MJ.
    Surg Infect (Larchmt); 2003 Feb 15; 4(1):57-70. PubMed ID: 12744768
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Linezolid: safety and efficacy in special populations.
    Gould FK.
    J Antimicrob Chemother; 2011 May 15; 66 Suppl 4():iv3-iv6. PubMed ID: 21521705
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.
    Wible K, Tregnaghi M, Bruss J, Fleishaker D, Naberhuis-Stehouwer S, Hilty M.
    Pediatr Infect Dis J; 2003 Apr 15; 22(4):315-23. PubMed ID: 12690270
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.
    Stevens DL, Smith LG, Bruss JB, McConnell-Martin MA, Duvall SE, Todd WM, Hafkin B.
    Antimicrob Agents Chemother; 2000 Dec 15; 44(12):3408-13. PubMed ID: 11083648
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
    Craft JC, Moriarty SR, Clark K, Scott D, Degenhardt TP, Still JG, Corey GR, Das A, Fernandes P.
    Clin Infect Dis; 2011 Jun 15; 52 Suppl 7():S520-6. PubMed ID: 21546629
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.